IGI Logo

About the Company

Nureca Ltd is a B2C company engaged in the business of home healthcare and wellness products, which offers quality, durability, functionality, usability and innovative designs. They enable their customers with tools to help them monitor chronic ailments and other diseases, to improve their lifestyle. Currently, the company operates under brand such as Dr. Trust, Dr. Physio and Trumom. Its product portfolio largely supports home health market in India, making it a one-stop solution provider. Further, their products are classified under 5 categories such as Chronic Device Products, Orthopedic Products, Mother and Child Products, Nutrition Supplements and Lifestyle Products. They are a digital first company wherein they sell products through online channel partners such as e-commerce players, distributors and retailer. Additionally they sell their products through its website ‘drtrust.in’. During Covid-19 pandemic, company’s products such as oximeter, gluco meter, nebulizer and BP monitor were categorized under the essential goods’ and their operations were not shut down as these products helped the user from visiting the hospitals during the lockdown.

Objects of the Issue

* Funding incremental working capital requirements of the company

* General corporate purposes

Key Strengths & Strategies

Strong product portfolio with focus on quality and innovation:

The company has strong product portfolio under home health segment and going forward it plans to innovate more such products which will be useful for consumers. Further, their products quality are well maintained as the company needs to adhere to guidelines given by FDA.

Asset light business model:

Nureca operate on an asset light business model wherein it enters into agreements with vendors who manufactures their products as per the specifications given and thereby maintaining quality. This helps the company to be capital efficient, add new products at a low cost without disrupting its existing business and manage cash flow efficiently.

Diversifying and strengthening market presence:

The company’s motive is to expand in the unorganized home healthcare sector in India. Further, expanding the scale of operations as well as growing supply chain network in new geographies via online and offline channels will aid growth of customer base as well as revenues.

Key Risks:

* Highly dependent on third party manufacturing.

* Intense competition from other players in healthcare product device industry

* Failure to adhere to regulations by FDA and numerous other state and central governmental authorities.

To Read Complete Report & Disclaimer Click Here

Please refer disclaimer http://ex.religareonline.com/disclaimer

SEBI Registration number is INZ000174330

Above views are of the author and not of the website kindly read disclaimer